{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:38:29Z","timestamp":1783953509909,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institutes of Health, University of the Philippines Manila"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41397-019-0143-8","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:14:56Z","timestamp":1578010496000},"page":"533-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association of carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients"],"prefix":"10.1038","volume":"20","author":[{"given":"Francis","family":"Capule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramote","family":"Tragulpiankit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surakameth","family":"Mahasirimongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraphun","family":"Jittikoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanjun","family":"Wichukchinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Theresa Alentajan-Aleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay-V","family":"James Barit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Casanova-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Cabral-Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Paciano","family":"Baltazar Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymark","family":"Salonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina Faith","family":"San Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lynn Silao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"143_CR1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl J Med. 1994;331:1272\u201385.","journal-title":"N. Engl J Med"},{"key":"143_CR2","unstructured":"Onishi ECC, Roa FDC. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis at the Philippine General Hospital: a seven-year retrospective study (January 2004 to December 2010). J Phil Dermatol Soc. 2013;22:29\u201337."},{"key":"143_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bjd.15360","volume":"177","author":"HY Lee","year":"2017","unstructured":"Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens\u2013Johnson syndrome\/ toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up. Br J Dermatol. 2017;177:924\u201335.","journal-title":"Br J Dermatol"},{"key":"143_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.dsi.2013.09.007","volume":"31","author":"HY Lee","year":"2013","unstructured":"Lee HY, Martanto W, Thirumoorthy T. Epidemiology of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Southeast Asia. Dermatol Sin. 2013;31:217\u201320.","journal-title":"Dermatol Sin"},{"key":"143_CR5","unstructured":"Uppsala Monitoring Centre. Carbamazepine and SJS\/TEN. 2018. https:\/\/www.who-umc.org\/vigibase\/vigilyze\/. Accessed 5 Mar 2018"},{"key":"143_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens\u2013Johnson syndrome. Nature. 2004;428:486.","journal-title":"Nature"},{"key":"143_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","volume":"16","author":"SI Hung","year":"2006","unstructured":"Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16:297\u2013306.","journal-title":"Pharmacogenet Genomics"},{"key":"143_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CBL Man","year":"2007","unstructured":"Man CBL, Kwan P, Baum L, Yu E, Lau KM, Cheng ASH, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia. 2007;48:1015\u20138.","journal-title":"Epilepsia"},{"key":"143_CR9","first-page":"252","volume":"50","author":"WP Liao","year":"2009","unstructured":"Liao WP, Shi YW, Cheng SH, Ng MH, Kwan P. Association between HLA-B*1502 allele and cutaneous reactions induced by carbamazepine or lamotrigine in Han Chinese. Epilepsia. 2009;50:252\u20133.","journal-title":"Epilepsia"},{"key":"143_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","volume":"19","author":"XT Wu","year":"2010","unstructured":"Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P. et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav. 2010;19:405\u20138.","journal-title":"Epilepsy Behav"},{"key":"143_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","volume":"67","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharm. 2011;67:885\u20137.","journal-title":"Eur J Clin Pharm"},{"key":"143_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","volume":"20","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhou JQ, Zhou LM, Chen ZY, Fang ZY, Chen SD, et al. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure. 2011;20:446\u20138.","journal-title":"Seizure"},{"key":"143_CR13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","volume":"111","author":"YW Shi","year":"2012","unstructured":"Shi YW, Min FL, Qin B, Zou X, Liu XR, Gao MM, et al. Association between HLA and Stevens\u2013Johnson Syndrome induced by carbamazepine in southern Han Chinese: genetic markers besides B*1502. Basic Clin Pharm Toxicol. 2012;111:58\u201364.","journal-title":"Basic Clin Pharm Toxicol"},{"key":"143_CR14","first-page":"S16","volume":"20","author":"PKL Kwan","year":"2014","unstructured":"Kwan PKL, Ng MHL, Lo SV. Association between HLA-B*15:02 allele and antiepileptic drug-induced severe cutaneous reactions in Hong Kong Chinese: a population-based study. Hong Kong Med J. 2014;20:S16\u20138.","journal-title":"Hong Kong Med J"},{"key":"143_CR15","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, et al. Carbamazepine and phenytoin induced Stevens\u2013Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. 2008;49:2087\u201391.","journal-title":"Epilepsia"},{"key":"143_CR16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia. 2010;51:926\u201330.","journal-title":"Epilepsia"},{"key":"143_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","volume":"12","author":"K Kulkantrakorn","year":"2012","unstructured":"Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, et al. HLA-B*1502 strongly predicts carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Pain Pract. 2012;12:202\u20138.","journal-title":"Pain Pract"},{"key":"143_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2780272","volume":"2018","author":"C Sukasem","year":"2018","unstructured":"Sukasem C, Chaichan C, Nakkrut T, Satapornpong P, Jaruthamsophon K, Jantararoungtong T, et al. Association between HLA-B alleles and carbamazepine-induced maculopapular exanthema and severe cutaneous reactions in Thai patients. J Immunol Res. 2018;2018:1\u201311.","journal-title":"J Immunol Res"},{"key":"143_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0378-6323.57718","volume":"75","author":"TY Mehta","year":"2009","unstructured":"Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens\u2013Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol. 2009;75:579\u201382.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"143_CR20","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1111\/epi.12802","volume":"55","author":"AHP Khor","year":"2014","unstructured":"Khor AHP, Lim KS, Tan CT, Wong SM, Ng CC. HLA-B*15:02 association with carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis. Epilepsia. 2014;55:e120\u20134.","journal-title":"Epilepsia"},{"key":"143_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","volume":"50","author":"CC Chang","year":"2011","unstructured":"Chang CC, Too CL, Murad S, Hussein SH. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens\u2013Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol. 2011;50:221\u20134.","journal-title":"Int J Dermatol"},{"key":"143_CR22","first-page":"290","volume":"29","author":"SM Then","year":"2011","unstructured":"Then SM, Rani ZZM, Raymond AA, Ratnaningrum S, Jamal R. Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysia epilepsy patients. Asian Pac J Allergy Immunol. 2011;29:290\u20133.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"143_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5415\/apallergy.2015.5.2.68","volume":"5","author":"DV Nguyen","year":"2015","unstructured":"Nguyen DV, Chu HC, Nguyan DV, Phan MH, Craig T, Baumgart K, et al. HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese. Asia Pac Allergy. 2015;5:68\u201377.","journal-title":"Asia Pac Allergy"},{"key":"143_CR24","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2217\/pgs-2017-0103","volume":"18","author":"R Yuliwulandari","year":"2017","unstructured":"Yuliwulandari R, Kristin E, Prayuni K, Sachrowardi Q, Suyatna FD, Menaldi SL, et al. Association of the HLA-B alleles with carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype. Pharmacogenomics. 2017;18:1643\u20138.","journal-title":"Pharmacogenomics"},{"key":"143_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/clpt.2013.55","volume":"94","author":"U Amstutz","year":"2013","unstructured":"Amstutz U, Ross CJD, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, et al. HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children. Clin Pharm Ther. 2013;94:142\u20139.","journal-title":"Clin Pharm Ther"},{"key":"143_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","volume":"97","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee KW, Song WJ, Kim SH, Jee YK, Lee SM, et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res. 2011;97:190\u20137.","journal-title":"Epilepsy Res"},{"key":"143_CR27","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","volume":"9","author":"N Kaniwa","year":"2008","unstructured":"Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics. 2008;9:1617\u201322.","journal-title":"Pharmacogenomics"},{"key":"143_CR28","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia. 2010;51:2461\u20135.","journal-title":"Epilepsia"},{"key":"143_CR29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1346-8138.2008.00548.x","volume":"35","author":"M Kashiwagi","year":"2008","unstructured":"Kashiwagi M, Aihara M, Takahashi Y, Yamazaki E, Yamane Y, Song Y, et al. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol. 2008;35:683\u20135.","journal-title":"J Dermatol"},{"key":"143_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1346-8138.2011.01457.x","volume":"39","author":"H Niihara","year":"2012","unstructured":"Niihara H, Kakamu T, Fujita Y, Kaneko S, Morita E. HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population. J Dermatol. 2012;39:594\u2013601.","journal-title":"J Dermatol"},{"key":"143_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/14622416.7.6.813","volume":"7","author":"A Alfirevic","year":"2006","unstructured":"Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics. 2006;7:813\u20138.","journal-title":"Pharmacogenomics"},{"key":"143_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008;18:99\u2013107.","journal-title":"Pharmacogenet Genomics"},{"key":"143_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","volume":"14","author":"E Genin","year":"2014","unstructured":"Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, et al. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J. 2014;14:281\u20138.","journal-title":"Pharmacogenomics J"},{"key":"143_CR34","unstructured":"Allele Frequency Net Database. 2016. http:\/\/allelefrequencies.net\/. Accessed 25 Sep 2019."},{"key":"143_CR35","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis. N. Engl J Med. 1995;333:1600\u20137.","journal-title":"N. Engl J Med"},{"key":"143_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharm Ther. 1981;30:239\u201345.","journal-title":"Clin Pharm Ther"},{"key":"143_CR37","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N. Engl J Med. 2011;364:1126\u201333.","journal-title":"N. Engl J Med"},{"key":"143_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1353\/phs.2015.0044","volume":"63","author":"FC Delfin","year":"2015","unstructured":"Delfin FC. the population history of the philippines: a genetic overview. Philipp Stud Hist Ethnogr Viewp. 2015;63:449\u201376.","journal-title":"Philipp Stud Hist Ethnogr Viewp"},{"key":"143_CR39","unstructured":"Lewis MP, Simons GF, Fennig CD Ethnologue: Language of the World. [monograph online]. 19th ed. Dallas, Texas: SIL International; 2016. https:\/\/www.ethnologue.com\/. Accessed 12 Dec 2016."},{"key":"143_CR40","unstructured":"PGH Background Information. 2017. http:\/\/www.pgh.gov.ph\/en\/about-us-1\/. Accessed 30 Nov 2018"},{"key":"143_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep45553","volume":"7","author":"K Jaruthamsophon","year":"2017","unstructured":"Jaruthamsophon K, Tipmanee V, Sangiemchoey A, Sukasem C, Limprasert P. HLA-B*15:21 and carbamazepine-induced Stevens\u2013Johnson syndrome: pooled-data and in silico analysis. Sci Rep. 2017;7:45553 https:\/\/doi.org\/10.1038\/srep45553","journal-title":"Sci Rep"},{"key":"143_CR42","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, Chen YT, Hung S. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens\u2013Johnson syndrome. J Allergy Clin Immunol. 2012;129:1562\u201369.","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41397-019-0143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-019-0143-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-019-0143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T16:24:16Z","timestamp":1722270256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-019-0143-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1038\/s41397-019-0143-8","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"14 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the University of the Philippines Manila Research Ethics Board with study protocol code UPMREB 2017-096-01 and by the Faculty of Dentistry and Faculty of Pharmacy Institutional Review Board, Mahidol University with reference number 0517.0319\/364.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}